North Star Investment Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.9K | Hold |
600
| – | – | ﹤0.01% | 642 |
|
|
2025
Q1 | $52K | Hold |
600
| – | – | ﹤0.01% | 605 |
|
|
2024
Q4 | $49.6K | Hold |
600
| – | – | ﹤0.01% | 615 |
|
|
2024
Q3 | $52.2K | Hold |
600
| – | – | ﹤0.01% | 589 |
|
|
2024
Q2 | $49.3K | Hold |
600
| – | – | ﹤0.01% | 599 |
|
|
2024
Q1 | $48.1K | Hold |
600
| – | – | ﹤0.01% | 616 |
|
|
2023
Q4 | $45.7K | Hold |
600
| – | – | ﹤0.01% | 603 |
|
|
2023
Q3 | $43.4K | Hold |
600
| – | – | ﹤0.01% | 611 |
|
|
2023
Q2 | $45.4K | Hold |
600
| – | – | ﹤0.01% | 623 |
|
|
2023
Q1 | $45.6K | Hold |
600
| – | – | ﹤0.01% | 633 |
|
|
2022
Q4 | $47.2K | Hold |
600
| – | – | ﹤0.01% | 605 |
|
|
2022
Q3 | $43K | Hold |
600
| – | – | ﹤0.01% | 571 |
|
|
2022
Q2 | $45K | Hold |
600
| – | – | ﹤0.01% | 563 |
|
|
2022
Q1 | $48K | Hold |
600
| – | – | ﹤0.01% | 587 |
|
|
2021
Q4 | $49K | Hold |
600
| – | – | ﹤0.01% | 613 |
|
|
2021
Q3 | $46K | Hold |
600
| – | – | ﹤0.01% | 605 |
|
|
2021
Q2 | $48K | Hold |
600
| – | – | ﹤0.01% | 590 |
|
|
2021
Q1 | $47K | Hold |
600
| – | – | ﹤0.01% | 561 |
|
|
2020
Q4 | $43K | Hold |
600
| – | – | ﹤0.01% | 557 |
|
|
2020
Q3 | $38K | Hold |
600
| – | – | ﹤0.01% | 555 |
|
|
2020
Q2 | $39K | Hold |
600
| – | – | 0.01% | 529 |
|
|
2020
Q1 | $33K | Hold |
600
| – | – | ﹤0.01% | 558 |
|
|
2019
Q4 | $39K | Buy |
+600
| New | +$39K | ﹤0.01% | 598 |
|